Lois Leister, the pharmacy Director at MCDH, has confirmed that Mendocino Coast District Hospital has at no time purchased any methylprednisolone acetatate injection which has been produced and distributed by New England Compounding Center (NECC) in Framingham, Massachusetts.
The FDA investigation into the exact source of the outbreak is still ongoing, but the outbreak that has been associated with this product is preservative-free methylprednisolone acetate (80mg/ml), an injectable steroid , produced and distributed by New England Compounding Center (NECC) in Framingham, Massachusetts. CDC’s interim data show that all infected patients received injection with this product.
